Furthermore, some biotechnology companies are investigating the potential indications for recombinant LBP, including various solid tumors, diabetic foot ulcers, psoriasis, the rare skin disorder Netherton syndrome, and phenylketonuria. Here, LBP is linked to Netherton syndrome.